Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis: Cochrane systematic review

Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis: Cochrane systematic review ID - 435128 BT - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435128/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis:_Cochrane_systematic_review DB - Evidence Central DP - Unbound Medicine ER -